Regional Diabetes Conference Sponsorship
Diabetes prevention and management in the RQHR is planned, delivered and evaluated within the context of the Prevention and Management Model for Chronic Disease (Expanded Chronic Care Model) and is informed by the Provincial Diabetes Plan and the RQHR vision, mission and strategic themes. The RQHR brings together a broad-based community support network to address the determinants of health. There is robust multi-sectoral collaboration and cooperation around health promotion, diabetes prevention, and diabetes management strategies. Programs are informed and driven with input from a grass roots level.
This conference specializes in pediatric dialysis and chronic kidney disease management. This conference convenes an international group of practitioners and researchers to discuss current development in the field of dialysis.
Transport Team Training
To establish provincial team training to promote and facilitate child health related care while traveling throughout the province. The program is to provide opportunities for mentoring that generate high quality, relevant research results. The training undertaken has a prompt and direct impact on improving transport care.
Evidence Live Conference
The purpose is to ensure that practitioners recognize and apply the current best evidence to each person, factoring in that person’s unique medical situations. It has become integral in the delivery of child health and the teaching of EBM is mandated for under and post graduates and had been adopted by all healthcare disciples.
Pediatric Continuous Renal Replacement Therapy Conference
A highly specialized treatment conference for children, who are septic, overdosed, metabolically challenged and severely fluid overloaded. These patients receive ventilator support, hemodynamic monitoring, cardiac support meds, and ant-infective therapies with parenteral nutrition regimes. This care is extremely complex. This conference focuses on providing knowledge and education to improve the outcomes for those children who develop or at risk of renal injury and failure.
Society for Adolescent Health & Medicine Conference
Transferring care from the adolescence to the adult system usually happens at age 18 while they are trying to cope with a multitude of developmental tasks. Pediatric and adult care settings are very different and more responsibility is shifted to the adolescent in adult care models. The need for a transition clinic and process has been increasingly apparent. The conference focuses on transitions and promoting health through adolescence and young adulthood. The outcome to educate peers and families through the process of transitioning, empowering them to feel ready to leave the care providers they have known and confident in their ability to navigate the system that will continue to provide them care through the rest of their life.
University of Saskatchewan
Visual enhancement of pediatric outpatients’ window file with healthy imagery.
The Loft Program
Families in need receive food and gift hampers to help throughout the holiday season.
Advanced Trauma Life Support (ATLS) Manuals
Manuals for Pediatric Transport Education.
Breast Pumps (2)
Symphony is the only evidence based breast pump helping mothers achieve more milk faster. It is the first electric hospital grade breast pump to mimic a baby’s two rhythm nursing pattern by using technology that pumps in an initial rapid stimulation phase, then a slower expression phase.
Milk Warmers (5)
Eliminates contamination risk associated with warming feedings in water. Consistently warms milk to temperatures similar to expressed human milk and safely thaws milk in less than 30 minutes to refrigerated temperature for storage up to 24 hours.
Point of Care Ultrasounds (2)
Pediatric point of care ultrasound is necessary for direct visualization of large and small veins in order to minimize complications from multiple attempts and maximize efficiency in obtaining venous access in a child undergoing an uncomfortable procedure. The ultrasound is also used for early diagnosis of life threatening events such as pneumothorax and pericardial tamponade. It provides information that can trigger lifesaving measures.
Infant Evacuation System (2)
Trialed by NICU, it is the only product for emergency evacuation that is safe for newborns and infants. It provides one nurse with the capability of evacuating six babies allowing them to glide down a flight of stairs with no bouncing.
NICU & Post-Partum
Transcutaneous Jaundice Meters (12)
The JM105 is the most technologically advanced model useful for premature babies as small as 26 weeks. The accuracy tested meters with custom calibrated nomograms are cornerstone to the recently implemented neonatal hyperbilirubinemia screening programs at the Department of Pediatrics. The non-invasive meter measures the yellowness of the tissue via a flash of light when pressed gently to the baby’s sternum. It also reduces blood serum testing on babies. The meters will make the sustainability of the newborn jaundice screening program more viable, effective and comprehensive. (An addition was ordered and designated to the Pelican Narrows location.)
Philips IntelliVue TcG210 Transcutaneous Monitor
Respiratory Therapy is responsible for supporting the ventilation of acutely ill children from across the province. In order to assess the effectiveness of ventilation and response to therapy a patient’s oxygen and carbon dioxide levels must be assessed, this is typically done through a blood test. With the use of a transcutaneous sensor and monitor patients can be assessed non-invasively allowing children in hospital to receive fewer pokes.
Vital Signs Monitor
The purpose of the vital signs monitor is to quickly obtain accurate vital sign measurements during a child’s clinic visit in the Pediatric Outpatient Department. Patients who primarily benefit from this piece of equipment are children with suspected or confirmed congenital and acquired heart defects. Accurate and quick measurement of blood pressure and oxygen saturation are key to making timely treatment decisions.
INR Point of Care Machines
Children & adolescents on oral anticoagulation therapy present special challenges in terms of rapid fluctuations in the monitoring of their International Normalised Radio (INR) values, interruption of daily life due to frequent hospital visits as well as difficulties and pain in the performance of venepuncture. Patient self-testing with INR Point of Care machines is being recognized as improving the quality of care for selected pediatric patients on anticoagulation. The program requires ten INR Point of Care machines to be used in outpatient by those who will benefit most from being a part of the INR Point of Care program due to their locations, treatment and fluctuation of anticoagulation management.
Plasmapheresis is technology that can remove components from the blood. This can range from toxins in metabolic diseases, WBC’s in cancer patients, immune mediators in kidney disease and inflammatory mediators in children with infection. Without the machine, this lifesaving service is unavailable to pediatric patients in Saskatchewan.
Fetal Echo Monito
A fetal echocardiogram is an ultrasound performed of the baby’s heart before the baby is born. The Fetal Echo Monitor will allow pregnant women and physician to view the scan of the fetus allowing the physician to explain as they go.
Crash Carts (2)
The crash cart is the trolley for storing lifesaving equipment and drugs for PICU.
Fetal Monitors (2)
Used during labour to monitor fetal heartbeat and maternal uterine contractions. The current monitors do not allow the transducers to be in water, newer models allow for this. With these new monitors women in labor who require monitoring can be in the shower or tub which many women find helpful.
Pediatric Transport Team Outerwear
The Transport Team provides pediatric tertiary care to all rural and tertiary care locations in Saskatchewan. This team utilizes both road and air ambulance service. Always in uniform, the winter jackets and pants are needed to perform daily transport services in harsh climate conditions.
New standards in education require the Department of Pediatrics to train in a simulation environment. This includes the SimNewB Simulator Manikin and SimPad System with clinical accessory kit. With realistic newborn trains and lifelike clinical feedback, SimNewB is ideal for training for the specific needs of neonates and allows learners to practice a large range of neonatal skills within a realistic simulation environment.
Designated Funds Enhancements
NICU/PICU/PEDS and Child Life designated funds enhancements are used to fund items such as glide rockers, toys, books, computer equipment and more.
Air Canada Transport Program
RQHR & SHR
Funds used to enhance the playrooms in Saskatoon and Regina
Dr. Huntsman, Assoc. Professor & Division Head, Pediatric Neurology
“Cannabidiol in Children with Refractory Epileptic Encephalopathy: A Phase 1 Open Label Dose Escalation Study”
Epileptic Encephalopathy Syndromes seizures are very difficult to control despite patients being placed on multiple medications. Since treatments often cause significant side effects there is a need to find therapies that are effective and better tolerated for children.
There has been significant media interest regarding medical marijuana products for the treatment of seizures in children. Hemp oil products with high cannabidiol (CBD) and low tetrahydrocannabinol (THC) ratios have been reported to provide seizure relief and cognitive improvement in children who take them. Parents have asked for these products to treat their children but due to lack of clinical information, physicians are often reluctant to prescribe. There is an urgent need to advance research on this treatment option. This study is to assess the safety and tolerability of a Health Canada approved high CBD: low THC product in children with refractor Epileptic Encephalopathy. Children enrolled will be monitored for quality of life and seizure frequency.
Marta Erlandson, PhD, Assistant Professor – College of Kinesiology – University of Saskatchewan
“A Pilot Health Intervention Study for Children with Congenital Heart Defects: CHAMPS – Children’s Healthy Heart Camp in Saskatchewan”
Congenital Heart defects (CHD) are a leading type of birth defect effecting approximately 2000 Saskatchewan kids. Survival rates of these children have steadily increased with upwards of 85% now living into adulthood. These children are less physically active than healthy peers and at a greater risk of mental health issues. Very little is known and there is no comprehensive chronic disease management (CDM) program to address their health needs. This research will explore the physical and mental health of children with CHD and pilot a supervised CDM program. 30 Saskatchewan children aged 7-13 will participate in a 1 week CHAMPS camp that promotes activity, healthy habits and psychological well- being. Body composition, cardiovascular and psychological, and health anxiety will be measured. These then will be compared to 30 healthy children. The project will be the first of its kind to focus on specific aspects of physical and psychological health of children with CHD and to pilot new, innovative programming tailored to their health concerns. This project is a vital first step in the development of a national CDM program to optimize growth, physical development, and mental health of children with CHD while minimizing future chronic disease risk factors.
Dr. Krista Baerg, Department of Pediatrics
“Accuracy & Precision Testing of JM-105 Transcutaneous Jaundice Meter”
Newborn jaundice affects approximately 60% of infants with 2% requiring treatment. Jaundice screening takes place within 72 hours of birth to determine if treatment or additional follow up is required. Transcutaneous technology allows for non-invasive testing at the bedside with immediate results as well as reduced need for painful blood draws, reduced time waiting for specimen transportation and processing and challenges related to contacting the family in community for follow up. Accuracy and precision testing of 16 new JM-105 meters must be undertaken before they can be integrated into existing protocols.
Dr. Alan Rosenberg, Department of Pediatrics
“The Biologic Basis of Co-existent Uveitis and Arthritis in Children: Towards Early Detection, Targeted Treatment and Prevention”
Arthritis is among the most common chronic disabling diseases of childhood affecting an estimated 1 in 1000 Canadian children. 60% of children with arthritis will continue to have arthritis as adults. In addition to inflammation of their joints children can also experience uveitis, a form of eye inflammation, which can result in serious deterioration of eyesight potentially leading to permanent vision loss. The reasons why are unknown and it is challenging for the doctor to accurately predict the onset of uveitis.
This study will explore the connection between uveitis and arthritis. Investigation of the structure of collagen, an important protein found in the joint and the eye which is altered by certain other proteins in a way that promotes inflammation at these sites. Using the information discovered in animals, testing on children will occur to predict outcomes.
Determining the mechanisms that explain the associations, more specific treatments and insight into possible causes of the condition will be found.
Dr. Hassan Vatanparast & Dr. Alan Rosenberg – Head, Division of Pediatrics & College of Pharmacy/Nutrition – University of Saskatchewan.
“The Impact of Vitamin D on Disease Activity in Children with Juvenile Idiopathic Arthritis”
Juvenile idiopathic arthritis (JLA; idiopathic means the cause is unknown) is one of the most common chronic diseases, and an important cause of disability in Canadian children. In Saskatchewan it is estimated that 1 in 1000 children have JIA. Causes are not understood but likely include both genetic and environmental influences. One factor that may play a role in influencing the occurrence and outcomes of JIA is vitamin D.
Vitamin D is reported to play a role in the reduction of disease activity in autoimmune diseases including JIA by suppressing inflammation which consequently reduces the symptoms and signs. 80% of children with JIA have low levels of vitamin D. No Canadian study has investigated the relationship between the two. The aim is to understand the association between the two. Patients with the onset of JIA from multiple centres were enrolled in the Biologically Based Outcome Predictors in JIA cohort study. Existing data will be used to explore the association between vitamin D status and measures of disease activity and explore a potential genetic variability in vitamin D receptors in JIA patients.
This study will be the first to investigate both the genetic and environmental role that vitamin D plays in controlling JIA. Through this study, there is hope to have data for specific guidelines for vitamin D in management of JIA patients.
Dr. Darryl Adamko, College of Medicine – University of Saskatchewan
“Improved Diagnosis of Pediatric Asthma: Metabolomic Analysis of Urine”
Asthma is the most frequent chronic disease of children and the number one reason for pediatric emergency admissions in Canadian hospitals. The lung tissues of children with asthma become inflamed and treatment often requires anti-inflammatory drugs like inhaled or oral corticosteroids. Corticosteroids can have a number of unwanted side-effects and deciding when to treat or increase the dose is difficult for doctors to predict. This renders control of the asthma less than optimal. To measure inflammation, one could use a biopsy however this is potentially dangerous and painful. Other less invasive teste are available, but they are less accurate and not suited for the average doctor’s office. Overall there is an urgent need for a better test. Developing a novel method to measure changes in children with asthma using a urine sample is instrumental. The lung tissue damage from asthma creates unique markers in the body that can be measured in the urine. It is believed that measuring these biomarkers in the urine will reflect changes in the disease. It is suspect that the amount of these urine markers will decrease after the treatment of the diseases. Ultimately, hope is that the urine test will not only diagnose asthma better than available techniques but will also help to better adjust the amount of medicine a child needs.